Atomoxetine use associated with onset of a motor tic.
Patients with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for Tourette's Disorder and other tic disorders. Stimulant medications and bupropion have been associated with the onset or exacerbation of a tic disorder. The selective norepinephrine reuptake inhibitor, atomoxetine, has been proposed to be an alternative medication for patients with ADHD and a comorbid tic disorder. This paper reviews a case study in which the onset of a motor tic was associated with a trial of the medication atomoxetine. Further research is needed to determine if atomoxetine is an appropriate alternative medication in patients with ADHD and a comorbid tic disorder.
Ledbetter
Marcialee
M
Department of Psychiatry and Pediatrics, University of Oklahoma-Tulsa, Tulsa, Oklahoma 74135, USA. Marcialee-Ledbetter@ouhsc.edu
D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002648:Child; D006801:Humans; D008297:Male; D011437:Propylamines / Q000009:adverse effects*; D013981:Tic Disorders / Q000139:chemically induced / Q000175:diagnosis; D020323:Tics / Q000139:chemically induced* / Q000175:diagnosis*
D011437:Propylamines; D000069445:Atomoxetine Hydrochloride